R&D tax offset refund
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- New Patent to Discover Sophisticated Cell Penetrating Drugs
- Entitlement Issue and Note Conversion
- Combination therapy escalates potency of Phylogica peptides
- US Patent Synthetic Phylomer Libraries
- US Patent granted
Later from PYC Therapeutics
- Pfizer First Stage of Collaboration Complete
- Share Placement raises $2.15 Million
- Technology Licence to Janssen Biotech
- Phylogica Accesses Novel Half-Life Extension Technology
- Phylogica - New Potential For Treating Brain Injury
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics